#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3616294	B	Displacement of [3H]N6-R-phenylisopropyladenosine from human adenosine A1 receptor expressed in CHO cell membranes at 10 uM	Homo sapiens	15	ALA3612017	cell-based format	Scientific Literature
2.	ALA3616296	B	Displacement of [3H]2-[p-(2-carboxyethyl)phenyl-ethylamino]-5'-Nethylcarboxamidoadenosine from human adenosine A2A receptor expressed in HEK293 cell membranes at 10 uM	Homo sapiens	18	ALA3612017	cell-based format	Scientific Literature
3.	ALA3616297	B	Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide from human adenosine A3 receptor expressed in CHO cell membranes	Homo sapiens	18	ALA3612017	cell-based format	Scientific Literature
4.	ALA3616298	B	Displacement of [3H]MRS1754 from human adenosine A2B receptor expressed in HEK293 cell membranes at 10 uM	Homo sapiens	2	ALA3612017	cell-based format	Scientific Literature
5.	ALA3616300	B	Binding affinity to mouse adenosine A3 receptor expressed in HEK293 cell membranes	Mus musculus	5	ALA3612017	cell-based format	Scientific Literature
6.	ALA3616301	B	Binding affinity to canine adenosine A3 receptor expressed in HEK293 cell membranes	Canis lupus familiaris	5	ALA3612017	cell-based format	Scientific Literature
7.	ALA3616302	B	Binding affinity to 5HT2B receptor (unknown origin)	Homo sapiens	2	ALA3612017	single protein format	Scientific Literature
8.	ALA3616304	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as protection of ipsilateral hind paw mechanoallodynia of sciatic nerve at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7 relative to control measured at 1 hr	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
9.	ALA3616305	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as protection of ipsilateral hind paw mechanoallodynia of sciatic nerve at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7 measured at 3 hrs	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
10.	ALA3616306	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as time of peak protection at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
11.	ALA3616311	A	Effect on contralateral side hind paw in mouse chronic constriction injury model of neuropathic pain at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
12.	ALA4011340	B	Enhancing of [125I]RTI-55 binding to recombinant human DAT expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
13.	ALA4011341	B	Enhancing of [3H]mazindol binding to recombinant human DAT expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
14.	ALA4011342	B	Enhancing of [125I]RTI-55 binding to recombinant human NET expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
15.	ALA4011343	B	Inhibition of recombinant human DAT expressed in HEK293 cell membranes assessed as reduction in [3H]-DA uptake incubated for 22 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
16.	ALA4011344	B	Enhancing of [3H]mazindol binding to recombinant human NET expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	12	ALA4007505	cell-based format	Scientific Literature
17.	ALA4011345	B	Inhibition of recombinant human NET expressed in HEK293 cell membranes assessed as reduction in [3H]-norepinephrine uptake incubated for 22 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
18.	ALA4011346	B	Enhancing of [125I]RTI-55 binding to recombinant human SERT expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature
19.	ALA4011347	B	Enhancing of [3H]mazindol binding to recombinant human SERT expressed in HEK293 cell membranes preincubated for 10 mins followed by radioligand addition measured after 90 mins by micro beta scintillation counting analysis	Homo sapiens	10	ALA4007505	cell-based format	Scientific Literature
20.	ALA4011348	B	Inhibition of recombinant human SERT expressed in HEK293 cell membranes assessed as reduction in [3H]5-HT uptake incubated for 22 mins by micro beta scintillation counting analysis	Homo sapiens	13	ALA4007505	cell-based format	Scientific Literature